Enovis Corporation
44.80
-0.55 (-1.21%)
At close: Jan 14, 2025, 3:59 PM
46.98
4.85%
After-hours Jan 14, 2025, 07:37 PM EST

Company Description

Enovis Corporation operates as a medical technology company worldwide.

It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformities, traumatic events, and sports related injuries.

It offers rigid and soft orthopedic bracings, hot and cold therapy products, bone growth stimulators, vascular therapy systems and compression garments, therapeutic shoes and inserts, electrical stimulators used for pain management, and physical therapy products; and a suite of reconstructive joint products for the hip, knee, shoulder, elbow, foot, ankle, and finger.

Enovis Corporation sells its products through independent distributors, such as healthcare professionals, consumer retail stores, and pharmacies; and directly under the DJO brand.

The company was formerly known as Colfax Corporation.

Enovis Corporation is headquartered in Wilmington, Delaware.

Enovis Corporation
Enovis Corporation logo
Country United States
IPO Date May 8, 2008
Industry Industrial - Machinery
Sector Industrials
Employees 6,550
CEO Matthew L. Trerotola

Contact Details

Address:
2711 Centerville Road
Wilmington, Delaware
United States
Website https://www.enovis.com

Stock Details

Ticker Symbol ENOV
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001420800
CUSIP Number 194014502
ISIN Number US1940145022
Employer ID 54-1887631
SIC Code 3842

Key Executives

Name Position
Matthew L. Trerotola Chief Executive Officer & Chairman
Bradley J. Tandy J.D. Senior Vice President & Chief Legal Officer
Phillip Benjamin Berry Senior Vice President & Chief Financial Officer
Brady R. Shirley Executive Advisor & Director
Daniel A. Pryor Executive Vice President of Strategy & Business Development
Derek Leckow J.D. Vice President of Investor Relations
John Kleckner Vice President, Controller & Chief Accounting Officer
Katie Sweet Vice President of Corporate Communication
Patricia A. Lang Senior Vice President & Chief Human Resources Officer
Tim Czartoski President of U.S. Surgical and Global Product & Enabling Technologies

Latest SEC Filings

Date Type Title
Jan 13, 2025 8-K Current Report
Jan 03, 2025 4 Filing
Nov 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial own...
Nov 13, 2024 SCHEDULE 13G Filing
Nov 06, 2024 10-Q Quarterly Report
Nov 06, 2024 8-K Current Report
Oct 01, 2024 4 Filing
Aug 07, 2024 4 Filing
Aug 07, 2024 4 Filing
Aug 07, 2024 4 Filing